×
The Clinical Management of Bipolar Disorder: A Review of Evidence-Based Guidelines PDF
$ 40.00
The Clinical Management of Bipolar Disorder: A Review of Evidence-Based Guidelines PDF quantity
$ 40.00
×
Neuropsychiatric Presentation of Anti-N -Methyl-d-Aspartate Receptor Encephalitis With Comorbid Sinus Venous Thrombosis PDF
$ 40.00
Neuropsychiatric Presentation of Anti-N-Methyl-d-Aspartate Receptor Encephalitis With Comorbid Sinus Venous Thrombosis PDF quantity
$ 40.00
×
A Self-Compassion Group Intervention for Patients Living With Chronic Medical Illness: Treatment Development and Feasibility Study PDF
$ 40.00
A Self-Compassion Group Intervention for Patients Living With Chronic Medical Illness: Treatment Development and Feasibility Study PDF quantity
$ 40.00
×
Minor Versus Major Depression: A Comparative Clinical Study PDF
$ 40.00
Minor Versus Major Depression: A Comparative Clinical Study PDF quantity
$ 40.00
×
Provider and Patient Characteristics Associated With Antidepressant Nonadherence: The Impact of Provider Specialty PDF
$ 40.00
Provider and Patient Characteristics Associated With Antidepressant Nonadherence: The Impact of Provider Specialty PDF quantity
$ 40.00
×
Posttraumatic Stress Disorder and Quality of Life: Results Across 64 Weeks of Sertraline Treatment PDF
$ 40.00
Posttraumatic Stress Disorder and Quality of Life: Results Across 64 Weeks of Sertraline Treatment PDF quantity
$ 40.00
×
Machine Learning Algorithms in Suicide Prevention: Clinician Interpretations as Barriers to Implementation PDF
$ 40.00
Machine Learning Algorithms in Suicide Prevention: Clinician Interpretations as Barriers to Implementation PDF quantity
$ 40.00
×
The Renin-Angiotensin Pathway in Posttraumatic Stress Disorder: Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Are Associated With Fewer Traumatic Stress Symptoms PDF
$ 40.00
The Renin-Angiotensin Pathway in Posttraumatic Stress Disorder: Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Are Associated With Fewer Traumatic Stress Symptoms PDF quantity
$ 40.00
×
Factors Associated With Posttraumatic Stress Symptoms 3 and 6 Months After Hospitalization for COVID-19: A Longitudinal Multicenter Study PDF
$ 40.00
Factors Associated With Posttraumatic Stress Symptoms 3 and 6 Months After Hospitalization for COVID-19: A Longitudinal Multicenter Study PDF quantity
$ 40.00
×
A Comprehensive Model of Predictors of Recurrence or Persistence in Individuals With Panic Disorder: Results From a National 3-Year Prospective Study PDF
$ 40.00
A Comprehensive Model of Predictors of Recurrence or Persistence in Individuals With Panic Disorder: Results From a National 3-Year Prospective Study PDF quantity
$ 40.00
×
Brain-Derived Neurotrophic Factor and Initial Antidepressant Response to an N -Methyl-d-Aspartate Antagonist PDF
$ 40.00
Brain-Derived Neurotrophic Factor and Initial Antidepressant Response to an N-Methyl-d-Aspartate Antagonist PDF quantity
$ 40.00
×
Psychiatric Features in High-Functioning Adult Brothers With Fragile X Spectrum Disorders PDF
$ 40.00
Psychiatric Features in High-Functioning Adult Brothers With Fragile X Spectrum Disorders PDF quantity
$ 40.00
×
Psychiatrists' and Nonpsychiatrist Physicians' Reported Use of the DSM-IV Criteria for Major Depressive Disorder PDF
$ 40.00
Psychiatrists' and Nonpsychiatrist Physicians' Reported Use of the DSM-IV Criteria for Major Depressive Disorder PDF quantity
$ 40.00
×
Transcranial Magnetic Stimulation for the Treatment of Obsessive-Compulsive Disorder PDF
$ 40.00
Transcranial Magnetic Stimulation for the Treatment of Obsessive-Compulsive Disorder PDF quantity
$ 40.00
×
The Threat of Behavioral Changes in Dementia PDF
$ 40.00
The Threat of Behavioral Changes in Dementia PDF quantity
$ 40.00
×
Effects of Electroconvulsive Therapy on Functional Outcomes Among Medicare Patients With Comorbid Depression and Dementia: A Nationwide 1-Year Follow-Up Study PDF
$ 40.00
Effects of Electroconvulsive Therapy on Functional Outcomes Among Medicare Patients With Comorbid Depression and Dementia: A Nationwide 1-Year Follow-Up Study PDF quantity
$ 40.00
×
Psilocybin Can Diminish Depression PDF
$ 40.00
Psilocybin Can Diminish Depression PDF quantity
$ 40.00
×
Relationship of Persistent Manic Symptoms to the Diagnosis of Pediatric Bipolar Spectrum Disorders PDF
$ 40.00
Relationship of Persistent Manic Symptoms to the Diagnosis of Pediatric Bipolar Spectrum Disorders PDF quantity
$ 40.00
×
Detection of Subclinical Depression in Bipolar Disorder: A Cross-Sectional, 4-Month Prospective Follow-Up Study at Community Mental Health Services (SIN-DEPRES) PDF
$ 40.00
Detection of Subclinical Depression in Bipolar Disorder: A Cross-Sectional, 4-Month Prospective Follow-Up Study at Community Mental Health Services (SIN-DEPRES) PDF quantity
$ 40.00
×
Can Using a Detoxification Kit Result in Bizarre Behavior and Hallucinations? PDF
$ 40.00
Can Using a Detoxification Kit Result in Bizarre Behavior and Hallucinations? PDF quantity
$ 40.00
×
Methamphetamine-Induced Catatonia PDF
$ 40.00
Methamphetamine-Induced Catatonia PDF quantity
$ 40.00
×
Compliance in Schizophrenia: Psychopathology, Side Effects, and Patients' Attitudes Toward the Illness and Medication PDF
$ 40.00
Compliance in Schizophrenia: Psychopathology, Side Effects, and Patients' Attitudes Toward the Illness and Medication PDF quantity
$ 40.00
×
Longitudinal Predictive Validity of the DSM-5 Anxious Distress Specifier for Clinical Outcomes in a Large Cohort of Patients With Major Depressive Disorder PDF
$ 40.00
Longitudinal Predictive Validity of the DSM-5 Anxious Distress Specifier for Clinical Outcomes in a Large Cohort of Patients With Major Depressive Disorder PDF quantity
$ 40.00
×
Conventional, Atypical, and Combination Antipsychotic Prescriptions: A 2-Year Comparison PDF
$ 40.00
Conventional, Atypical, and Combination Antipsychotic Prescriptions: A 2-Year Comparison PDF quantity
$ 40.00
×
Bridging Community Mental Health and Primary Care to Improve Medication Monitoring and Outcomes for Patients With Mental Illness Taking Second-Generation Antipsychotics—Phase 2: Quality Improvement Initiative Over 15 Months PDF
$ 40.00
Bridging Community Mental Health and Primary Care to Improve Medication Monitoring and Outcomes for Patients With Mental Illness Taking Second-Generation Antipsychotics—Phase 2: Quality Improvement Initiative Over 15 Months PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart